5-Chlorotryptamine

Pharmaceutical compound From Wikipedia, the free encyclopedia

5-Chlorotryptamine (5-Cl-T; developmental code name PAL-441) is a serotonin receptor modulator and monoamine releasing agent of the tryptamine family.[1] It is the 5-chloro derivative of tryptamine.[1]

Other names5-Chloro-T; 5-Cl-T; 5-ClT; PAL-441; PAL441
ATC code
  • None
Quick facts Clinical data, Other names ...
5-Chlorotryptamine
Clinical data
Other names5-Chloro-T; 5-Cl-T; 5-ClT; PAL-441; PAL441
Drug classSerotonin receptor modulator; Serotonin 5-HT2A receptor agonist; Serotonin releasing agent
ATC code
  • None
Identifiers
  • 2-(5-chloro-1H-indol-3-yl)ethanamine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.021.077 Edit this at Wikidata
Chemical and physical data
FormulaC10H11ClN2
Molar mass194.66 g·mol−1
3D model (JSmol)
  • C1=CC2=C(C=C1Cl)C(=CN2)CCN
  • InChI=1S/C10H11ClN2/c11-8-1-2-10-9(5-8)7(3-4-12)6-13-10/h1-2,5-6,13H,3-4,12H2
  • Key:FVQKQPVVCKOWLM-UHFFFAOYSA-N
Close

The drug shows affinity for the serotonin 5-HT1A, 5-HT2A, 5-HT6, and 5-HT7 receptors (Ki = 5.5–16 nM, 317–889 nM, 38 nM, and 16 nM, respectively).[2][3][4] It acts as a potent agonist of the serotonin 5-HT1A receptor (EC50Tooltip half-maximal effective concentration = 3,846 nM) and of the 5-HT2A receptor (EC50 = 4.11–145 nM; EmaxTooltip maximal efficacy = 109%).[1][3][4] In addition, 5-chlorotryptamine is a serotonin releasing agent (SRA), with EC50 values for induction of monoamine release of 19.1 nM for serotonin, 476 nM for dopamine, and >10,000 nM for norepinephrine in rat brain synaptosomes.[1] Similarly to tryptamine and other simple amine-unsubstituted tryptamines, 5-chlorotryptamine was ineffective in producing the head-twitch response, a behavioral proxy of psychedelic effects, in rodents.[3][4]

Tryptamines without substitutions at the amine or alpha carbon, such as tryptamine, serotonin (5-hydroxytryptamine; 5-HT), and 5-methoxytryptamine (5-MeO-T), are known to be very rapidly metabolized and thereby inactivated by monoamine oxidase A (MAO-A) in vivo and to have very short elimination half-lives.[5][6][7][8][9][10][11] However, given intravenously at sufficiently high doses, tryptamine is still known to be able to produce weak and short-lived psychoactive effects in humans.[12][6][1][11]

The chemical synthesis of 5-chlorotryptamine has been described.[1]

5-Chlorotryptamine was first described in the scientific literature by 1959.[13][14]

See also

References

Related Articles

Wikiwand AI